| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |